Keros Therapeutics
(NASDAQ) KROS
Keros Therapeutics Financials at a Glance
Market Cap
$236.61M
Revenue (TTM)
$244.06M
Net Income (TTM)
$87.01M
EPS (TTM)
$1.82
P/E Ratio
6.59
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Price
$11.99
Volume
22,697
Open
$11.42
Price
$11.99
Volume
22,697
Open
$11.42
Previous Close
$11.99
Daily Range
$11.35 - $11.99
52-Week Range
$9.12 - $22.55
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Price
$11.99
Volume
22,697
Open
$11.42
Previous Close
$11.99
Daily Range
$11.35 - $11.99
52-Week Range
$9.12 - $22.55
KROS News
KROS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Keros Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
78
CEO
Jasbir S. Seehra, PhD
Website
www.kerostx.comHeadquarters
Lexington, MA 02421, US
KROS Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
29%
Net Income Margin
36%
Return on Equity
20%
Return on Capital
22%
Return on Assets
26%
Earnings Yield
15.17%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$236.61M
Shares Outstanding
19.72M
Volume
22.70K
Short Interest
0.00%
Avg. Volume
421.74K
Financials (TTM)
Gross Profit
$242.55M
Operating Income
$70.62M
EBITDA
$72.13M
Operating Cash Flow
$107.50M
Capital Expenditure
$1.55M
Free Cash Flow
$105.95M
Cash & ST Invst.
$287.42M
Total Debt
$16.88M
Keros Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$385.00K
-87.3%
Gross Profit
$15.00K
-100.6%
Gross Margin
-3.90%
N/A
Market Cap
$236.61M
N/A
Market Cap/Employee
$1.45M
N/A
Employees
163
N/A
Net Income
$23.46M
+49.0%
EBITDA
$28.79M
+1.2%
Quarterly Fundamentals
Net Cash
$270.53M
-50.0%
Accounts Receivable
$6.37M
+43.0%
Inventory
$0.00
N/A
Long Term Debt
$14.47M
-14.3%
Short Term Debt
$2.41M
+21.7%
Return on Assets
25.74%
N/A
Return on Invested Capital
22.24%
N/A
Free Cash Flow
$27.43M
+40.8%
Operating Cash Flow
$27.29M
+40.7%